GeneDx Holdings Corp.
WGS
$106.65
-$1.70-1.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 137.05% | 67.74% | 121.10% | 80.34% | 37.56% |
| Total Depreciation and Amortization | 18.65% | 8.19% | 1,020.55% | -31.63% | -49.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -57.56% | 22.70% | -352.54% | -47.17% | 425.32% |
| Change in Net Operating Assets | -360.64% | 143.62% | 7.21% | 60.85% | 64.69% |
| Cash from Operations | 331.30% | 162.04% | 89.34% | 89.34% | 91.58% |
| Capital Expenditure | -75.22% | -1,283.52% | -28.37% | -476.79% | 51.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.32% | -354.98% | 196.05% | 73.93% | -2,135,000.00% |
| Cash from Investing | -60.13% | -1,216.01% | 89.33% | 71.41% | -101.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -61.55% | -97.19% | -4.30% | 22.39% | -201.71% |
| Issuance of Common Stock | 775.18% | 60,854.17% | 171,221.05% | -- | -98.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 188.49% | 3,231.96% | -34.14% | 1,633.26% | -105.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.29% | 190.53% | 120.67% | 102.62% | 51.91% |